1 Market Overview

1.1 Product Overview and Scope of Convalescent Plasma Therapy

1.2 Classification of Convalescent Plasma Therapy by Type

1.2.1 Overview: Global Convalescent Plasma Therapy Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Convalescent Plasma Therapy Revenue Market Share by Type in 2020

1.2.3 IgM

1.2.4 IgG

1.2.5 IgA

1.3 Global Convalescent Plasma Therapy Market by Application

1.3.1 Overview: Global Convalescent Plasma Therapy Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Prophylaxis

1.3.3 Treatment

1.4 Global Convalescent Plasma Therapy Market Size & Forecast

1.5 Global Convalescent Plasma Therapy Market Size and Forecast by Region

1.5.1 Global Convalescent Plasma Therapy Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Convalescent Plasma Therapy Market Size by Region, (2016-2021)

1.5.3 North America Convalescent Plasma Therapy Market Size and Prospect (2016-2026)

1.5.4 Europe Convalescent Plasma Therapy Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Convalescent Plasma Therapy Market Size and Prospect (2016-2026)

1.5.6 South America Convalescent Plasma Therapy Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Convalescent Plasma Therapy Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Convalescent Plasma Therapy Market Drivers

1.6.2 Convalescent Plasma Therapy Market Restraints

1.6.3 Convalescent Plasma Therapy Trends Analysis

2 Company Profiles

2.1 Bio Farma

2.1.1 Bio Farma Details

2.1.2 Bio Farma Major Business

2.1.3 Bio Farma Convalescent Plasma Therapy Product and Solutions

2.1.4 Bio Farma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Bio Farma Recent Developments and Future Plans

2.2 Grifols

2.2.1 Grifols Details

2.2.2 Grifols Major Business

2.2.3 Grifols Convalescent Plasma Therapy Product and Solutions

2.2.4 Grifols Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Grifols Recent Developments and Future Plans

2.3 Hilton Pharma

2.3.1 Hilton Pharma Details

2.3.2 Hilton Pharma Major Business

2.3.3 Hilton Pharma Convalescent Plasma Therapy Product and Solutions

2.3.4 Hilton Pharma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Hilton Pharma Recent Developments and Future Plans

2.4 Biotest

2.4.1 Biotest Details

2.4.2 Biotest Major Business

2.4.3 Biotest Convalescent Plasma Therapy Product and Solutions

2.4.4 Biotest Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Biotest Recent Developments and Future Plans

2.5 BPL

2.5.1 BPL Details

2.5.2 BPL Major Business

2.5.3 BPL Convalescent Plasma Therapy Product and Solutions

2.5.4 BPL Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 BPL Recent Developments and Future Plans

2.6 LFB

2.6.1 LFB Details

2.6.2 LFB Major Business

2.6.3 LFB Convalescent Plasma Therapy Product and Solutions

2.6.4 LFB Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 LFB Recent Developments and Future Plans

2.7 Octapharma

2.7.1 Octapharma Details

2.7.2 Octapharma Major Business

2.7.3 Octapharma Convalescent Plasma Therapy Product and Solutions

2.7.4 Octapharma Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Octapharma Recent Developments and Future Plans

2.8 CSL Behring

2.8.1 CSL Behring Details

2.8.2 CSL Behring Major Business

2.8.3 CSL Behring Convalescent Plasma Therapy Product and Solutions

2.8.4 CSL Behring Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 CSL Behring Recent Developments and Future Plans

2.9 Takeda Pharmaceutical Company Limited

2.9.1 Takeda Pharmaceutical Company Limited Details

2.9.2 Takeda Pharmaceutical Company Limited Major Business

2.9.3 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product and Solutions

2.9.4 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Takeda Pharmaceutical Company Limited Recent Developments and Future Plans

2.10 Orthosera Kft

2.10.1 Orthosera Kft Details

2.10.2 Orthosera Kft Major Business

2.10.3 Orthosera Kft Convalescent Plasma Therapy Product and Solutions

2.10.4 Orthosera Kft Convalescent Plasma Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Orthosera Kft Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Convalescent Plasma Therapy Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Convalescent Plasma Therapy Players Market Share

3.2.2 Top 10 Convalescent Plasma Therapy Players Market Share

3.2.3 Market Competition Trend

3.3 Convalescent Plasma Therapy Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Convalescent Plasma Therapy Revenue and Market Share by Type (2016-2021)

4.2 Global Convalescent Plasma Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Convalescent Plasma Therapy Revenue Market Share by Application (2016-2021)

5.2 Convalescent Plasma Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Convalescent Plasma Therapy Revenue by Type (2016-2026)

6.2 North America Convalescent Plasma Therapy Revenue by Application (2016-2026)

6.3 North America Convalescent Plasma Therapy Market Size by Country

6.3.1 North America Convalescent Plasma Therapy Revenue by Country (2016-2026)

6.3.2 United States Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

6.3.3 Canada Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

6.3.4 Mexico Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Convalescent Plasma Therapy Revenue by Type (2016-2026)

7.2 Europe Convalescent Plasma Therapy Revenue by Application (2016-2026)

7.3 Europe Convalescent Plasma Therapy Market Size by Country

7.3.1 Europe Convalescent Plasma Therapy Revenue by Country (2016-2026)

7.3.2 Germany Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

7.3.3 France Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

7.3.5 Russia Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

7.3.6 Italy Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Convalescent Plasma Therapy Revenue by Type (2016-2026)

8.2 Asia-Pacific Convalescent Plasma Therapy Revenue by Application (2016-2026)

8.3 Asia-Pacific Convalescent Plasma Therapy Market Size by Region

8.3.1 Asia-Pacific Convalescent Plasma Therapy Revenue by Region (2016-2026)

8.3.2 China Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

8.3.3 Japan Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

8.3.4 South Korea Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

8.3.5 India Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

8.3.7 Australia Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Convalescent Plasma Therapy Revenue by Type (2016-2026)

9.2 South America Convalescent Plasma Therapy Revenue by Application (2016-2026)

9.3 South America Convalescent Plasma Therapy Market Size by Country

9.3.1 South America Convalescent Plasma Therapy Revenue by Country (2016-2026)

9.3.2 Brazil Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

9.3.3 Argentina Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Convalescent Plasma Therapy Revenue by Type (2016-2026)

10.2 Middle East & Africa Convalescent Plasma Therapy Revenue by Application (2016-2026)

10.3 Middle East & Africa Convalescent Plasma Therapy Market Size by Country

10.3.1 Middle East & Africa Convalescent Plasma Therapy Revenue by Country (2016-2026)

10.3.2 Turkey Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

10.3.4 UAE Convalescent Plasma Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Convalescent Plasma Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Convalescent Plasma Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Convalescent Plasma Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Convalescent Plasma Therapy Revenue (USD Million) by Region (2016-2021)

Table 5. Global Convalescent Plasma Therapy Revenue Market Share by Region (2021-2026)

Table 6. Bio Farma Corporate Information, Head Office, and Major Competitors

Table 7. Bio Farma Major Business

Table 8. Bio Farma Convalescent Plasma Therapy Product and Solutions

Table 9. Bio Farma Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Grifols Corporate Information, Head Office, and Major Competitors

Table 11. Grifols Major Business

Table 12. Grifols Convalescent Plasma Therapy Product and Solutions

Table 13. Grifols Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Hilton Pharma Corporate Information, Head Office, and Major Competitors

Table 15. Hilton Pharma Major Business

Table 16. Hilton Pharma Convalescent Plasma Therapy Product and Solutions

Table 17. Hilton Pharma Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Biotest Corporate Information, Head Office, and Major Competitors

Table 19. Biotest Major Business

Table 20. Biotest Convalescent Plasma Therapy Product and Solutions

Table 21. Biotest Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. BPL Corporate Information, Head Office, and Major Competitors

Table 23. BPL Major Business

Table 24. BPL Convalescent Plasma Therapy Product and Solutions

Table 25. BPL Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. LFB Corporate Information, Head Office, and Major Competitors

Table 27. LFB Major Business

Table 28. LFB Convalescent Plasma Therapy Product and Solutions

Table 29. LFB Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Octapharma Corporate Information, Head Office, and Major Competitors

Table 31. Octapharma Major Business

Table 32. Octapharma Convalescent Plasma Therapy Product and Solutions

Table 33. Octapharma Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. CSL Behring Corporate Information, Head Office, and Major Competitors

Table 35. CSL Behring Major Business

Table 36. CSL Behring Convalescent Plasma Therapy Product and Solutions

Table 37. CSL Behring Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Takeda Pharmaceutical Company Limited Corporate Information, Head Office, and Major Competitors

Table 39. Takeda Pharmaceutical Company Limited Major Business

Table 40. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product and Solutions

Table 41. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Orthosera Kft Corporate Information, Head Office, and Major Competitors

Table 43. Orthosera Kft Major Business

Table 44. Orthosera Kft Convalescent Plasma Therapy Product and Solutions

Table 45. Orthosera Kft Convalescent Plasma Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Global Convalescent Plasma Therapy Revenue (USD Million) by Players (2019-2021)

Table 47. Global Convalescent Plasma Therapy Revenue Share by Players (2019-2021)

Table 48. Breakdown of Convalescent Plasma Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Convalescent Plasma Therapy Players Head Office, Products and Services Provided

Table 50. Convalescent Plasma Therapy Mergers & Acquisitions in the Past Five Years

Table 51. Convalescent Plasma Therapy New Entrants and Expansion Plans

Table 52. Global Convalescent Plasma Therapy Revenue (USD Million) by Type (2016-2021)

Table 53. Global Convalescent Plasma Therapy Revenue Share by Type (2016-2021)

Table 54. Global Convalescent Plasma Therapy Revenue Forecast by Type (2021-2026)

Table 55. Global Convalescent Plasma Therapy Revenue by Application (2016-2021)

Table 56. Global Convalescent Plasma Therapy Revenue Forecast by Application (2021-2026)

Table 57. North America Convalescent Plasma Therapy Revenue by Type (2016-2021) & (USD Million)

Table 58. North America Convalescent Plasma Therapy Revenue by Type (2021-2026) & (USD Million)

Table 59. North America Convalescent Plasma Therapy Revenue by Application (2016-2021) & (USD Million)

Table 60. North America Convalescent Plasma Therapy Revenue by Application (2021-2026) & (USD Million)

Table 61. North America Convalescent Plasma Therapy Revenue by Country (2016-2021) & (USD Million)

Table 62. North America Convalescent Plasma Therapy Revenue by Country (2021-2026) & (USD Million)

Table 63. Europe Convalescent Plasma Therapy Revenue by Type (2016-2021) & (USD Million)

Table 64. Europe Convalescent Plasma Therapy Revenue by Type (2021-2026) & (USD Million)

Table 65. Europe Convalescent Plasma Therapy Revenue by Application (2016-2021) & (USD Million)

Table 66. Europe Convalescent Plasma Therapy Revenue by Application (2021-2026) & (USD Million)

Table 67. Europe Convalescent Plasma Therapy Revenue by Country (2016-2021) & (USD Million)

Table 68. Europe Convalescent Plasma Therapy Revenue by Country (2021-2026) & (USD Million)

Table 69. Asia-Pacific Convalescent Plasma Therapy Revenue by Type (2016-2021) & (USD Million)

Table 70. Asia-Pacific Convalescent Plasma Therapy Revenue by Type (2021-2026) & (USD Million)

Table 71. Asia-Pacific Convalescent Plasma Therapy Revenue by Application (2016-2021) & (USD Million)

Table 72. Asia-Pacific Convalescent Plasma Therapy Revenue by Application (2021-2026) & (USD Million)

Table 73. Asia-Pacific Convalescent Plasma Therapy Revenue by Region (2016-2021) & (USD Million)

Table 74. Asia-Pacific Convalescent Plasma Therapy Revenue by Region (2021-2026) & (USD Million)

Table 75. South America Convalescent Plasma Therapy Revenue by Type (2016-2021) & (USD Million)

Table 76. South America Convalescent Plasma Therapy Revenue by Type (2021-2026) & (USD Million)

Table 77. South America Convalescent Plasma Therapy Revenue by Application (2016-2021) & (USD Million)

Table 78. South America Convalescent Plasma Therapy Revenue by Application (2021-2026) & (USD Million)

Table 79. South America Convalescent Plasma Therapy Revenue by Country (2016-2021) & (USD Million)

Table 80. South America Convalescent Plasma Therapy Revenue by Country (2021-2026) & (USD Million)

Table 81. Middle East & Africa Convalescent Plasma Therapy Revenue by Type (2016-2021) & (USD Million)

Table 82. Middle East & Africa Convalescent Plasma Therapy Revenue by Type (2021-2026) & (USD Million)

Table 83. Middle East & Africa Convalescent Plasma Therapy Revenue by Application (2016-2021) & (USD Million)

Table 84. Middle East & Africa Convalescent Plasma Therapy Revenue by Application (2021-2026) & (USD Million)

Table 85. Middle East & Africa Convalescent Plasma Therapy Revenue by Country (2016-2021) & (USD Million)

Table 86. Middle East & Africa Convalescent Plasma Therapy Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Convalescent Plasma Therapy Picture

Figure 2. Global Convalescent Plasma Therapy Revenue Market Share by Type in 2020

Figure 3. IgM

Figure 4. IgG

Figure 5. IgA

Figure 6. Convalescent Plasma Therapy Revenue Market Share by Application in 2020

Figure 7. Prophylaxis Picture

Figure 8. Treatment Picture

Figure 9. Global Convalescent Plasma Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 10. Global Convalescent Plasma Therapy Revenue and Forecast (2016-2026) & (USD Million)

Figure 11. Global Convalescent Plasma Therapy Revenue Market Share by Region (2016-2026)

Figure 12. Global Convalescent Plasma Therapy Revenue Market Share by Region in 2020

Figure 13. North America Convalescent Plasma Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 14. Europe Convalescent Plasma Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Asia-Pacific Convalescent Plasma Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. South America Convalescent Plasma Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Middle East and Africa Convalescent Plasma Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Convalescent Plasma Therapy Market Drivers

Figure 19. Convalescent Plasma Therapy Market Restraints

Figure 20. Convalescent Plasma Therapy Market Trends

Figure 21. Bio Farma Recent Developments and Future Plans

Figure 22. Grifols Recent Developments and Future Plans

Figure 23. Hilton Pharma Recent Developments and Future Plans

Figure 24. Biotest Recent Developments and Future Plans

Figure 25. BPL Recent Developments and Future Plans

Figure 26. LFB Recent Developments and Future Plans

Figure 27. Octapharma Recent Developments and Future Plans

Figure 28. CSL Behring Recent Developments and Future Plans

Figure 29. Takeda Pharmaceutical Company Limited Recent Developments and Future Plans

Figure 30. Orthosera Kft Recent Developments and Future Plans

Figure 31. Global Convalescent Plasma Therapy Revenue Share by Players in 2020

Figure 32. Convalescent Plasma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 33. Global Top 3 Players Convalescent Plasma Therapy Revenue Market Share in 2020

Figure 34. Global Top 10 Players Convalescent Plasma Therapy Revenue Market Share in 2020

Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 36. Global Convalescent Plasma Therapy Revenue Share by Type in 2020

Figure 37. Global Convalescent Plasma Therapy Market Share Forecast by Type (2021-2026)

Figure 38. Global Convalescent Plasma Therapy Revenue Share by Application in 2020

Figure 39. Global Convalescent Plasma Therapy Market Share Forecast by Application (2021-2026)

Figure 40. North America Convalescent Plasma Therapy Sales Market Share by Type (2016-2026)

Figure 41. North America Convalescent Plasma Therapy Sales Market Share by Application (2016-2026)

Figure 42. North America Convalescent Plasma Therapy Revenue Market Share by Country (2016-2026)

Figure 43. United States Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Canada Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Mexico Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 46. Europe Convalescent Plasma Therapy Sales Market Share by Type (2016-2026)

Figure 47. Europe Convalescent Plasma Therapy Sales Market Share by Application (2016-2026)

Figure 48. Europe Convalescent Plasma Therapy Revenue Market Share by Country (2016-2026)

Figure 49. Germany Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. France Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. United Kingdom Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Russia Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Italy Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Asia-Pacific Convalescent Plasma Therapy Sales Market Share by Type (2016-2026)

Figure 55. Asia-Pacific Convalescent Plasma Therapy Sales Market Share by Application (2016-2026)

Figure 56. Asia-Pacific Convalescent Plasma Therapy Revenue Market Share by Region (2016-2026)

Figure 57. China Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Japan Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. South Korea Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. India Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Southeast Asia Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Australia Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South America Convalescent Plasma Therapy Sales Market Share by Type (2016-2026)

Figure 64. South America Convalescent Plasma Therapy Sales Market Share by Application (2016-2026)

Figure 65. South America Convalescent Plasma Therapy Revenue Market Share by Country (2016-2026)

Figure 66. Brazil Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Argentina Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Middle East and Africa Convalescent Plasma Therapy Sales Market Share by Type (2016-2026)

Figure 69. Middle East and Africa Convalescent Plasma Therapy Sales Market Share by Application (2016-2026)

Figure 70. Middle East and Africa Convalescent Plasma Therapy Revenue Market Share by Country (2016-2026)

Figure 71. Turkey Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Saudi Arabia Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. UAE Convalescent Plasma Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Methodology

Figure 75. Research Process and Data Source